Teva wins FDA approval for monthly schizophrenia injection Weltruza
- Posted on October 9, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Teva wins FDA approval for monthly schizophrenia injection Weltruza
Oct 9 (Reuters) - Teva said on Friday it had received approval from the US Food and Drug Administration for its Weltruza drug for extended-release injectable suspension as the first and only once-monthly subcutaneous injectable olanzapine for adults with schizophrenia. Israel-based Teva, which is leading the development and commercialisation of the treatment under its partnership with France's
